新型降尿酸药非布索坦的临床研究进展(3)
[2] Khosravan R， Kukulka MJ，Wu JT，et al.The effect of age and gender on pharmacokinetics， pharmacodynamics， and safety of febuxostat， a novel nonpurine selective inhibitor of xanthine[J].Clin Pharmacol.Epub，2008，48(9)：1014-1024.[3] Yanyan Zhu，Bhavik J.Pandya，Hyon K.Choi.Prevalence of Gout and Hyperuricemia in the US General Population The National Health and Nutrition Examination Survey 2007–2008[J].Arthritis & Rheumatism ......
您现在查看是摘要页，全文长 2732 字符。